ChromaDex Corp.
10005 Muirlands Boulevard
Suite G
Irvine,
CA 92618
United States - Map
Phone: 949-429-0288
| ChromaDex Corporation, through its subsidiaries, creates and supplies botanical reference standards, and related phytochemical products and services. It offers reference standards, materials, and kits to conduct quality control of raw materials and consumer products; fine chemicals and phytochemicals for research and new product development; Bioluminex, a bio-analytical method that identifies the presence of toxic or harmful compounds in water, dietary ingredients, food products, and food ingredients; and contract services ranging from routine contract analysis to contract research. The company also provides a range of consulting services, such as regulatory support, new ingredient or product development, risk management, and litigation support services; process development services; and intellectual property services. It serves dietary supplement, nutraceutical, food and beverage, functional food, pharmaceutical, and cosmetic markets. The company markets and sells its products in the United States and Canada. It offers its products through distributors in Europe, South America, Korea, India, Japan, Australia, New Zealand, China, Indonesia, Malaysia, Singapore, Thailand, and Mexico. ChromaDex Corporation was founded in 2000 and is headquartered in Irvine, California. |
|
| Key Statistics |
| |
| | Pay | Exercised | Mr. Frank L. Jaksch Jr., 40
Co-Founder, Co-Chairman, Chief Exec. Officer, Pres and
Member of Compensation Committee |
$
156.00K | N/A | Mr. Thomas C. Varvaro , 39
Chief Financial Officer, Principal Accounting Officer, Sec., Treasurer, Director and Chairman of Nominating & Corp. Governance Committee |
$
120.00K | N/A | Mr. Mark S. Germain , 58
Co-Founder, Co-Chairman and Member of Audit Committee |
N/A
| N/A | Mr. Brian Schaneberg Ph.D,
Director of Technical Services |
N/A
| N/A | Dr. James McChesney Ph.D,
Consulting Chief Scientific Officer and Member of Board of Advisors |
N/A
| N/A |
|
|
|
Dollar amounts are as of
31-Dec-08
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.28% Nasdaq 
Profile
